Mutations in EGFR lead to its overexpression, which results in its constant activation and uncontrolled cell division in many different cancers (e.g., non-small cell lung cancer (NSCLC), colorectal cancer, pancreatic cancer, etc.)[59,60,61]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.